Search Result "tyrosin-kinaseinhibitor"
Structure-Activity Relationship Studies on VEGFR2 Tyrosine KinaseInhibitors for Identification of Potential Natural Anticancer Compounds
Journal: Medicinal Chemistry
Volume: 20 Issue: 6 Year: 2024 Page: 646-661
Author(s): Prema Gauri Vasudev
Second-Generation Protein Kinase Inhibitor â A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia
Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 5 Year: 2019
Author(s): Xavier Thomas,Etienne Paubelle
Doi: 10.2174/9789811405150119050003
The Development of 3-substituted Indolin-2-one Derivatives as KinaseInhibitors for Cancer Therapy
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 11 Year: 2022 Page: 1891-1919
Author(s): Changqing Xu,Yang Liu,Guisen Zhao
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associatedwith Hepatocellular Carcinoma
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 6 Year: 2022 Page: 454-462
Author(s):
Lapatinib as a Dual Tyrosine Kinase Inhibitor Unexpectedly Activates Akt in MDA-MB-231 Triple-Negative Breast Cancer Cells
Journal: Letters in Drug Design & Discovery
Volume: 17 Issue: 8 Year: 2020 Page: 1060-1063
Author(s): Parham Jabbarzadeh Kaboli,King-Hwa Ling
An Anti-EGFR/anti- HER2 Bispecific Antibody with Enhanced Antitumor Activity Against Acquired Gefitinib-Resistant NSCLC Cells
Journal: Protein & Peptide Letters
Volume: 28 Issue: 11 Year: 2021 Page: 1290-1297
Author(s): Yan Si,Xinxin Pei,Xiangfang Wang,Qianqian Han,Changzhi Xu,Buchang Zhang
Targeting Small Molecule Tyrosine Kinases by Polyphenols: New Move Towards Anti-tumor Drug Discovery
Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 5 Year: 2020 Page: 585-615
Author(s): Nikhil S. Sakle,Shweta A. More,Sachin A. Dhawale,Santosh N. Mokale
Heterocyclization of 2-(2-phenylhydrazono)cyclohexane-1,3-dione to Synthesis Thiophene, Pyrazole and 1,2,4-triazine Derivatives with Anti-Tumor and Tyrosine Kinase Inhibitions
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 10 Year: 2020 Page: 1209-1220
Author(s): Rafat M. Mohareb,Ensaf S. Alwan
Prediction and Experimental Evaluation of the hERG Blocking Potentialof Drugs Showing Clinical Signs of Cardiotoxicity
Journal: Letters in Drug Design & Discovery
Volume: 20 Issue: 11 Year: 2023 Page: 1757-1767
Author(s):
Nilotinib, A Tyrosine Kinase Inhibitor, Suppresses the Cell Growth and TriggersAutophagy in Papillary Thyroid Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 3 Year: 2022 Page: 596-602
Author(s): Lei Meng,Pengxin Zhao,Zhigang Hu,Weiyuan Ma,Yong Niu,Jingwei Su,Yubo Zhang